NDC 16590-545

NDC 16590-545

NDC 16590-545 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 16590-545
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 16590-545-30 [16590054530]

Ondansetron TABLET, ORALLY DISINTEGRATING
Marketing CategoryANDA
Application NumberANDA078152
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-10-27
Inactivation Date2019-10-21

Drug Details


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.